Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

NEW YORK ( TheStreet) -- The markets are full of great "pin action," Jim Cramer told "Mad Money" viewers Thursday, donning his favorite bowling shirt and shoes and brandishing his bowling ball. To continue the metaphor, Cramer told viewers the ball is now rolling and the market is coming up with lots of strikes.

Today's good news started in China and Europe, which was great for all of the mining, minerals and metals stocks. The short squeeze on stocks like Caterpillar ( CAT - Get Report) may finally be over, as these international markets finally stabilize, he said.

But the good news didn't stop there. Cramer said the oil stocks followed suit, with Exxon Mobil ( XOM - Get Report) and EOG Resources ( EOG - Get Report) just two of the many oil stocks on the move higher today. There was strength in the transports and the rails as well as hopes of more commerce picks up.

With jobless rates falling, spending should be picking up as well, said Cramer, which is why everything from Starbucks ( SBUX - Get Report) to VF Corp ( VFC) headed higher, as did the banks, which have been reporting fewer loan losses this quarter.

Another standout has been the mobile Internet, with Yelp ( YELP - Get Report) shooting the lights out, rising 23% in a single day. Everything from Trulia ( TRLA) to Zillow ( Z - Get Report) saw the "pin action" from that news.

And the strikes kept on coming, said Cramer -- from FedEx ( FDX - Get Report) to ( AMZN - Get Report) and Netflix ( NFLX - Get Report).

No matter where you look, the pins are flying, Cramer concluded. That's great news for investors.

Executive Decision: David Pyott

In the "Executive Decision" segment, Cramer spoke with David Pyott, chairman and CEO of Allergan ( AGN - Get Report), a stock which was under pressure last quarter but was able to deliver a 2-cents-a-share earnings beat this quarter on a 10% rise in revenue.

Pyott responded to critics by saying everything is looking good at Allergan and he was very pleased to exceed its guidance and Wall Street's expectations on just about every metric. He also commented on the generic competition for the company's dry-eye product, which has many analysts worried.

Pyott explained that Allergan has responded to the Food and Drug Administration regarding the newcomer, pointing out several significant challenges and shortcomings that need to be addressed before a generic can come to market. Shortcuts are dangerous in the eye business, he said, and the FDA is aware of that.

Another worry for investors was a delay in Allergan's macular degeneration drug. Pyott said the product was indeed delayed but is not dead. Allergan is already recruiting patients for its new trial of the drug, which could be a gigantic opportunity for the company in 2017 and beyond.

Another bright spot for Allergan is, of course, Botox, which Pyott noted is ahead of plan in its many indications. In fact, he said, Botox gained share in the quarter globally, despite fierce competition. Botox now accounts for 80% of the world market.

Cramer said that Pyott had great answers for the concerns that were raised and he sees the stock as an opportunity at its current levels.

Money in Mobile

We all know that mobile, social and the cloud are the next drivers of Internet success, but until now only Facebook ( FB - Get Report) has shown that it can make money in mobile. That was, of course, until Yelp shocked investors with sales rising by 69%.

Cramer said that Yelp is winning in a number of different ways. First, as more and more people use the service, it becomes harder and harder for businesses of all types not to be on the service. And as more and more businesses get listed, well, that only drives more people to the site in a virtuous circle.

Second, as Yelp grows its user base, it's also growing its advertisers because advertising to those people who are already interested in your business and are looking it up makes a lot of sense. Yelp is rapidly becoming the next generation yellow pages, said Cramer, and that's a very powerful concept.

Finally, Cramer said that with Yelp's remarkable growth and dominant position, it becomes a natural takeover target, especially for a company like Apple ( AAPL - Get Report), a stock Cramer owns for his charitable trust, Action Alerts PLUS. Cramer said that Yelp must be bought by someone eventually, and that only makes the stock today all the more valuable.

Lightning Round

In the Lightning Round, Cramer was bullish on Cheniere Energy Partners ( CQP), DexCom ( DXCM - Get Report), Himax Technologies ( HIMX - Get Report), Pier 1 Imports ( PIR - Get Report), Celldex Therapeutics ( CLDX - Get Report) and Applied Materials ( AMAT - Get Report).

Cramer was bearish on SunPower ( SPWR - Get Report) and Chart Industries ( GTLS - Get Report).

Executive Decision: Phil Fernandez

In his second "Executive Decision" segment, Cramer sat down with Phil Fernandez, president and CEO of Marketo ( MKTO), the cloud marketing stock that's up nearly 45% since Cramer recommended it on June 10. Marketo just reported a stellar 62% rise in revenue for the quarter.

Fernandez said Marketo is pioneering a new category of marketing and this quarter proved to investors the category is for real. He said Marketo allows its customers to communicate with their customers through multiple channels, a concept which is resonating with many companies.

When asked about the company's many partnerships, Fernandez explained that what Marketo does is slightly different than what other vendors provide, which is why it is able to partner with companies including Microsoft ( MSFT - Get Report) and ( CRM - Get Report), which, on the surface, appear to have competing products.

With social media finally finding some advertising success, Fernandez said more and more advertisers are beginning to look at the platform, which only creates more success and makes Marketo more valuable since it can reach customers across those channels. Email, he said, is only a small part of engaging with customers in today's mobile and social world.

When asked about the company's finances, Fernandez reassured shareholders that Marketo is not currently planning any major equity offerings.

Cramer said he continues to like the Marketo story.

Executive Decision: Ron Cohen

In a third "Executive Decision" segment, Cramer sat down with Dr. Ron Cohen, president and CEO of Acorda Therapeutics ( ACOR - Get Report), a speculative biotech that's shot up 57% since Cramer recommended it back in June.

Cohen said Acorda's drug, Ampyra, has currently been tried by 80,000 patients with MS, but there are still another 120,000 patients that have yet to try the drug. When asked how Acorda gets the drug into the hands of more patients, Cohen said that it's simply a matter of educating more doctors on its incredible results, which have shown improvement in walking for many patients.

Acorda is not stopping with Ampyra, however, as Cohen noted that patients who have suffered a stroke can also benefit from Ampyra. The company is working on a new formulation for another clinical trial in the second quarter of 2014.

Cohen said that one of the key benefits of Ampyra is that it interacts well with other drugs, so it can often be taken in conjunction with other medications.

Cramer said Acorda remains an interesting speculative stock that investors should investigate.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC

At the time of publication, Cramer's Action Alerts PLUS had positions in AAPL and FB.

Jim Cramer, host of the CNBC television program "Mad Money," is a Markets Commentator for, Inc., and CNBC, and a director and co-founder of All opinions expressed by Mr. Cramer on "Mad Money" are his own and do not reflect the opinions of or its affiliates, or CNBC, NBC Universal or their parent company or affiliates. Mr. Cramer's opinions are based upon information he considers to be reliable, but neither, nor CNBC, nor either of their affiliates and/or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. Mr. Cramer's statements are based on his opinions at the time statements are made, and are subject to change without notice. No part of Mr. Cramer's compensation from CNBC or is related to the specific opinions expressed by him on "Mad Money."

None of the information contained in "Mad Money" constitutes a recommendation by Mr. Cramer, or CNBC that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the program. Mr. Cramer's past results are not necessarily indicative of future performance. Neither Mr. Cramer, nor, nor CNBC guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the program. The strategy or investments discussed may fluctuate in price or value and you may get back less than you invested. Before acting on any information contained in the program, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.

Some of the stocks mentioned by Mr. Cramer on "Mad Money" are held in Mr. Cramer's Action Alerts PLUS Portfolio. When that is the case, appropriate disclosure is made on the program and in the "Mad Money" recap available on The Action Alerts PLUS Portfolio contains all of Mr. Cramer's personal investments in publicly-traded equity securities only, and does not include any mutual fund holdings or other institutionally managed assets, private equity investments, or his holdings in, Inc. Since March 2005, the Action Alerts PLUS Portfolio has been held by a Trust, the realized profits from which have been pledged to charity. Mr. Cramer retains full investment discretion with respect to all securities contained in the Trust. Mr. Cramer is subject to certain trading restrictions, and must hold all securities in the Action Alerts PLUS Portfolio for at least one month, and is not permitted to buy or sell any security he has spoken about on television or on his radio program for five days following the broadcast.